Everolimus better for matters of the heart

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1653, 2008-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Costs no higher with everolimus in heart transplant

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 476, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Everolimus

By Chapman T.M. Perry C.M.

Drugs, Vol. 64, Iss. 8, 2004-01 ,pp. : 861-872

Adis International

Access to resources Recommend Favorite

Is everolimus useful in preventing allograft rejection and vasculopathy after heart transplant?

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 2, 2004-02 ,pp. : 161-163

Informa Healthcare

Access to resources Recommend Favorite

Beta-blockers: not the alpha male in matters of the heart

Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Better protection for patentees: preliminary injunctions in the EU for pharmaceutical patent matters

By von Falck Andreas Gundt Miriam

Pharmaceutical Patent Analyst, Vol. 2, Iss. 3, 2013-05 ,pp. : 291-293

Future Science

Access to resources Recommend Favorite